Block Grant K01DA015454

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $720,763 to Virginia Commonwealth University (VCU) to investigate the risk and protective factors associated with substance use trajectories in adolescents. The 4-year study will leverage data from the Adolescent Brain Cognitive Development (ABCD) study, which includes a large, nationwide sample of over 11,000 youth, as well as longitudinal...

This K01 career development grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to examine cognitive, behavioral, and brain-based markers of self-regulation as predictors of cannabis and alcohol co-use in adolescence. The $166,512 award to The Trustees of Columbia University in the City of New York will fund a longitudinal study to investigate how impairments in executive function and high impulsivity prior to...

This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...

This federal Project Grant award of $840,425.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research examining the impact of prenatal and postnatal substance exposure on adolescent risk behaviors. The award to The Pennsylvania State University will leverage a longitudinal sample of 247 families to investigate developmental cascades linking pre- and post-natal substance use risks to adolescent substance use,...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $233,250 to The Washington University in St. Louis to examine the relationship between early cannabis use and later opioid use disorder. The key objectives are to: 1) Estimate the association between early cannabis use and both proximal and distal aspects of opioid involvement, including whether the relationships are modified by co-occurring...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...

The University of Washington was awarded a $149,284 Project Grant by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the role of specific subpopulations of prefrontal cortex pyramidal neurons in regulating drug-seeking behavior. The research aims to elucidate the factors that predispose individuals to addiction and confer vulnerability to relapse, with the goal of advancing understanding of the functional roles of...

The National Institute on Drug Abuse (NIDA) awarded a $818,513 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Regents of the University of Minnesota to investigate the role of dopamine signaling in the basolateral amygdala in regulating individual differences in reward-based learning strategies and addiction-like behaviors. The 5-year grant, which commenced on Sep 15, 2024, will focus on examining how individual differences in Pavlovian reward learning approaches...

This Project Grant award of $1,519,496 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and implementation of a workforce intervention called PATH (Peer Advanced Training in Harm Reduction). The goal is to reduce burnout among Peer Recovery Support Specialists (PRSS) who deliver harm reduction services and improve service quality and system-level outcomes. The PATH intervention uses virtual education...

This federal Project Grant award of $703,457, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a longitudinal study to investigate the relationship between adolescent social media use and substance use. The primary goals are to: 1) Determine longitudinal associations and sensitive developmental windows linking social media use with substance use, 2) Identify mechanisms connecting social media use and substance use,...